Nektar Therapeutics Banner Image

Nektar Therapeutics

  • Ticker NKTR
    Exchange NASDAQ More
  • Industry Drug Delivery More
  • Sector Healthcare More
Nektar Therapeutics Logo Image
  • 501-1000 Employees
  • Based in San Francisco, California
Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. The company’s product pipeline consists of drug candidates across various therapeutic areas, including oncology, pain, anti-infectives, anti-viral, and immunology.
4.8 / 5.0 (196)

Nektar Therapeutics reports have an aggregate usefulness score of 4.8 based on 196 reviews.

Nektar Therapeutics

Most Recent Annual Report

Nektar Therapeutics
MOST RECENT 2023 Annual Report and Form 10K

Nektar Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Nektar Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!